Nova Labs

Nova Laboratories is a specialist pharmaceutical company and contract development and manufacturing organization (CDMO) based in the United Kingdom. The company focuses on the development and manufacture of complex sterile products, including clinical trial supplies and commercial orphan drugs. Nova is particularly recognized for its proprietary HydRIS platform, a stabilization technology that allows heat-sensitive biologics and vaccines to be converted into stable, dry-powder formats. Through its Nova Orphan division, the company commercializes niche pediatric therapies such as Xaluprine for acute lymphoblastic leukemia. Nova provides end-to-end services ranging from formulation development and aseptic filling to global clinical trial distribution.